Fujian Wanchen Biotechnology Co. Ltd (300972) — Cash Flow Quality Index
Fujian Wanchen Biotechnology Co. Ltd (300972) has a Cash Flow Quality Index of 2.70x as of December 2025. Operating cash flow of CN¥3.63 Billion exceeds net income of CN¥1.34 Billion, indicating high earnings quality where cash backs reported profits. Explore cash flow conversion of Fujian Wanchen Biotechnology Co. Ltd to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Fujian Wanchen Biotechnology Co. Ltd Cash Flow Quality Index (2019–2025)
Historical Cash Flow Quality Index for Fujian Wanchen Biotechnology Co. Ltd across 6 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Fujian Wanchen Biotechnology Co. Ltd (300972) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Fujian Wanchen Biotechnology Co. Ltd (2019–2025)
Year-by-year earnings quality comparison for Fujian Wanchen Biotechnology Co. Ltd. For live market cap and the full company financial profile, see market value of Fujian Wanchen Biotechnology Co. Ltd.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 2.70x | CN¥3.63 Billion | CN¥1.34 Billion | ▼ -6.6% |
| 2024 | 2.89x | CN¥848.35 Million | CN¥293.52 Million | ▲ +96.1% |
| 2022 | 1.47x | CN¥70.38 Million | CN¥47.77 Million | ▼ -63.8% |
| 2021 | 4.07x | CN¥98.82 Million | CN¥24.28 Million | ▲ +150.4% |
| 2020 | 1.63x | CN¥156.24 Million | CN¥96.13 Million | ▼ -15.5% |
| 2019 | 1.92x | CN¥177.28 Million | CN¥92.19 Million | — |